Compare GNK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNK | ABCL |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 849.7M | 910.0M |
| IPO Year | 2005 | 2020 |
| Metric | GNK | ABCL |
|---|---|---|
| Price | $23.60 | $3.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $19.00 | $7.75 |
| AVG Volume (30 Days) | 411.5K | ★ 3.7M |
| Earning Date | 05-20-2026 | 05-26-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | N/A | ★ 10.91 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $342,054,000.00 | $75,128,000.00 |
| Revenue This Year | $15.27 | N/A |
| Revenue Next Year | $4.07 | $6.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $11.20 | $1.89 |
| 52 Week High | $24.11 | $6.52 |
| Indicator | GNK | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 68.65 | 46.78 |
| Support Level | $15.58 | $2.75 |
| Resistance Level | N/A | $3.84 |
| Average True Range (ATR) | 0.79 | 0.19 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 84.51 | 76.47 |
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.